Dividend-adjusted total return · S&P 500 uses VOO · Oct 7, 2026 – Nov 5, 2026FTXHS&P 500 · VOO
First Trust Nasdaq Pharmaceuticals ETFFTXH
$43.13
−3.9% last session
+31.5% YTD
Data as of 11/5/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −3.9% | +6.0% | +9.1% | +31.5% | +45.7% | +87.0% | +77.1% | +138.8% |
| Peer average | −3.4% | +4.6% | +3.5% | +19.7% | +29.0% | +75.3% | +27.3% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $1.2B
- Expense ratio
- 0.60%
- Distribution yield
- 0.7%
- NAV
- $44.86
- Volume
- 68K
- Avg. volume 30D
- 262K
- High today
- $45.10
- Low today
- $43.11
- Previous close
- $44.86
- 52-week high
- $45.10
- 52-week low
- $29.85
- Our risk indicator
- 4/5
FTXH in One Breath
FTXH Among Health Care ETFs
YTDEnd-of-day Nov 6, 2026 · 33 Health care ETFs by YTD
$10,000 in FTXH
5Y$10,000 in FTXH became
$17,713
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
FTXH’s Top Holdings
TodayLLYEli Lilly and Company8.1%ABBV7.6%PFE7.1%JNJ6.9%MRK6.7%GILD3.9%BIIB3.9%REGN3.8%VTRS3.8%ZTS3.8%AMGN3.7%UTHR3.5%VRTX3.3%INCY3.3%BMY3.2%EXEL2.7%JAZZ2.5%HALO1.7%ILMN1.7%MEDP1.5%NBIX1.3%ELAN28 more
LLYEli Lilly and Company8.1%ABBV7.6%PFE7.1%JNJ6.9%MRK6.7%GILD3.9%BIIB3.9%REGN3.8%VTRS3.8%ZTS3.8%AMGNUTHR38 more
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - Diagnostics
First Trust FTXH · 50 holdings · tile size = share of the fund · as of Nov 5, 2026
What FTXH Holds
TodayDrug Manufacturers - General51.1%
LLY 8.1 · ABBV 7.6 · PFE 7.1 · JNJ 6.9 · MRK 6.7 · GILD 3.9 · BIIB 3.9
Biotechnology33.5%
REGN 3.8 · UTHR 3.5 · VRTX 3.3 · INCY 3.3 · EXEL 2.7 · JAZZ 2.5 · HALO 1.7
Drug Manufacturers - Specialty & Generic9.8%
VTRS 3.8 · ZTS 3.8 · ELAN 1.2 · AMRX · ALKS
Medical - Diagnostics & Research4.8%
ILMN 1.7 · MEDP 1.5 · CRL 1.0 · GH
Medical - Pharmaceuticals0.6%
CORT · LQDA
First Trust FTXH · share of the fund by industry · as of Nov 5, 2026
Eli’s Share of FTXH
Today8.1%
$81 of every $1,000 in FTXH is Eli
Eli held by FTXH
$97.9M
First Trust FTXH · each square = $10 of $1,000 · as of Nov 5, 2026
FTXH’s Share of Health Care ETFs
Today1.1%
of the $112B in 39 Health care ETFs
$1.2B1.1%
$50.9B45.4%
$19.1B17.0%
$40.9B36.5%
Health care ETF AUM · Nov 6, 2026
FTXH Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 6, 2026
Inside FTXH
50 holdings · as of Nov 5, 2026FTXH
First Trust Nasdaq Pharmaceuticals ETF
Today| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.10% |
| 2 | ABBV | AbbVie | 7.59% |
| 3 | PFE | Pfizer | 7.15% |
| 4 | JNJ | Johnson & Johnson | 6.87% |
| 5 | MRK | Merck & | 6.72% |
| 6 | GILD | Gilead Sciences | 3.94% |
| 7 | BIIB | Biogen | 3.88% |
| 8 | REGN | Regeneron Pharmaceuticals | 3.85% |
| 9 | VTRS | Viatris | 3.84% |
| 10 | ZTS | Zoetis | 3.82% |
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsMedical - Pharmaceuticals
First Trust FTXH · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 82.8%
All FTXH Holdings
51 holdings · as of Nov 5, 2026FTXH
FTXH’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.10% | $809.65 | 69K | $98.1M |
| 2 | ABBVAbbVie | Healthcare | 7.59% | $759.44 | 312K | $92.0M |
| 3 | PFEPfizer | Healthcare | 7.15% | $714.58 | 2.8M | $86.6M |
| 4 | JNJJohnson & Johnson | Healthcare | 6.87% | $686.55 | 301K | $83.2M |
| 5 | MRKMerck | Healthcare | 6.72% | $672.13 | 542K | $81.4M |
| 6 | GILDGilead Sciences | Healthcare | 3.94% | $393.75 | 273K | $47.7M |
| 7 | BIIBBiogen | Healthcare | 3.88% | $387.89 | 185K | $47.0M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 3.85% | $384.69 | 50K | $46.6M |
| 9 | VTRSViatris | Healthcare | 3.84% | $384.46 | 2.4M | $46.6M |
| 10 | ZTSZoetis | Healthcare | 3.82% | $382.08 | 519K | $46.3M |
| 11 | AMGNAmgen | Healthcare | 3.68% | $367.55 | 93K | $44.5M |
| 12 | UTHRUnited Therapeutics | Healthcare | 3.50% | $349.54 | 70K | $42.4M |
| 13 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.33% | $332.98 | 73K | $40.4M |
| 14 | INCYIncyte | Healthcare | 3.26% | $325.60 | 321K | $39.5M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.17% | $317.30 | 599K | $38.5M |
First Trust FTXH · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
FTXH
First Trust Nasdaq Pharmaceuticals ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put FTXH head to head with XLV →XLV vs FTXH
YTDYear to date
FTXH wins+10.6 pts
Past year
FTXH wins+16.1 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV42.1× more
2–2level
SPDR XLV and First Trust FTXH · year-to-date · as of Nov 6, 2026 · AUM not scored
FTXH vs VOO
YTDFTXH · First Trust Nasdaq Pharmaceuticals
+31.5%
VOO · S&P 500
+8.4%
Gap
23.1 pts
First Trust FTXH and Vanguard VOO · YTD total return · as of Nov 6, 2026
FTXH vs Its Peer Average
YTDFTXHAvsBPeer average
1D−3.9%−3.4%
1M+6.0%+4.6%
3M+9.1%+3.5%
YTD+31.5%+19.7%
1Y+45.7%+29.0%
3Y+87.0%+75.3%
5Y+77.1%+27.3%
6–1FTXH wins
38 Health care peers · each row scaled to its leader
The Details
FTXH
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y18.28%
Deepest drop · 1Y−7.5%
Lowest point · 5Y−6.0%
52-week range
$43.13
$29.85−4.4% from the high$45.10
First Trust FTXH · past-year price moves · as of Nov 6, 2026
FTXH
Fund Facts
Today2016launched Sep 20
Tracks[…]
Exchange · CUSIPNASDAQ · 33738R837
StructureETF
Leverage1x
Cost on $10,000$60 a year
Go deeper
First Trust FTXH · fund facts · as of Nov 6, 2026
FTXH
Payouts by Year
11Y$0.0113per share, Sep 2026
Distribution yield0.7%
PaidEvery quarter
Latest ex-date · paidSep 24 · Sep 30, 2026
12 payouts added up$1.20 a share
First Trust FTXH · distributions by ex-date · 2016–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗SEC reported portfolio · 2023-12-31 ↗SEC reported portfolio · 2023-09-29 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-12-30 ↗
Trading & Liquidity
Net asset value$44.86
Premium / discount[…]
Median spread · 30D[…]
Volume today68K
Average volume · 30D262K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.60%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$60.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |
Issuer contentFrom First TrustHear the strategy from the people behind FTXH.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →